Epidemiology of Parkinson's disease

A Elbaz; L Carcaillon; S Kab; F Moisan

doi:10.1016/j.neurol.2015.09.012

Epidemiology of Parkinson's disease

Rev Neurol (Paris). 2016 Jan;172(1):14-26. doi: 10.1016/j.neurol.2015.09.012. Epub 2015 Dec 21.

Authors

A Elbaz¹, L Carcaillon², S Kab³, F Moisan⁴

Affiliations

¹ Inserm, centre for research in epidemiology and population health, U1018, epidemiology of ageing and age related diseases, 94807 Villejuif, France; University Paris-Sud, UMRS 1018, 94807 Villejuif, France; Département santé travail, institut de veille sanitaire (InVS), 94415 Saint-Maurice, France. Electronic address: alexis.elbaz@inserm.fr.
² Département des maladies chroniques et des traumatismes, institut de veille sanitaire (InVS), 94415 Saint-Maurice, France.
³ Inserm, centre for research in epidemiology and population health, U1018, epidemiology of ageing and age related diseases, 94807 Villejuif, France; University Paris-Sud, UMRS 1018, 94807 Villejuif, France; Département santé travail, institut de veille sanitaire (InVS), 94415 Saint-Maurice, France.
⁴ Département santé travail, institut de veille sanitaire (InVS), 94415 Saint-Maurice, France.

PMID: 26718594
DOI: 10.1016/j.neurol.2015.09.012

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's. PD is considered a multifactorial disorder that results, in most cases, from the combined effects of multiple risk and protective factors, including genetic and environmental ones. This review discusses some of the methodological challenges involved in assessing the descriptive, prognostic and etiological epidemiological studies of PD, and summarizes their main findings.

Keywords: Epidemiology; Parkinson's disease.

Publication types

Review

MeSH terms

Humans
Incidence
Parkinson Disease / epidemiology*
Parkinson Disease / etiology
Prevalence
Prognosis
Risk Factors